Microemulsion based intranasal delivery system for treatment of insomnia

References

• Newer options in the management of insomnia, Dopheide JA, and Kushida AC, http://www.uspharmacist.com.
   Google Scholar
• Rey E, Treuler JM, and Pons G, “Pharmacokinetic optimization of benzodiazepine therapy for acute seizures: Focus on delivery routes, Clin Pharmacokinet 36(6) (1999), 409–424.
   PubMed Web of Science ®Google Scholar
• Bigal MEBordini CA, Antoniazzi AL, and Speciali JG, “The triptan formulations: a critical evaluation”, Arq Neuropsiqiatr 61(2A) (2003), 313–320.
   PubMed Web of Science ®Google Scholar
• Wermling DP, Miller JP, Archer SM, Manaligod JM, and Rudy AC, “Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous and intramuscular administration”, J ClinPharmacology 41(2001), 1225–1231.
   Web of Science ®Google Scholar
• Dorman DC, Brenneman KA, McElveen AM, Lynch SE, Roberts KC, and Wong BA“Olfactory transport: A direct route of delivery of inhaled manganese Phosphate to the rat brain”, J Toxicol Environ Health 65(20) (2002), 1493–1511.
   Web of Science ®Google Scholar
• Dragphia R, Caillaud C, Manicom R, Pavirani A, Kahn A, and Poenaru L, “Gene delivery into the central nervous system by nasal instillation in rats”, Gene Ther. 2 (6) (1995), 418–423.
   PubMed Web of Science ®Google Scholar
• Liu XF, Fawcett JR, Thorne RG, and Frey WH. “2nd intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage”, J Neurol Sci. 187(1) (2001), 91–97.
   PubMed Web of Science ®Google Scholar
• Lisbeth Illum “Transport of drugs from the nasal cavity to the central nervous system”, Eur J Pharm Sci. 11(1) (2000), 1–189
   PubMed Web of Science ®Google Scholar
• Lisbeth Illum, “Nasal Drug Delivery: new developments and strategies”, Drug Discovery Today. 7(23) (2002), 1184–1189.
   PubMed Web of Science ®Google Scholar
• Vyas TK, Shahiwala A, Marathe S, and Misra A, “Intranasal drug delivery for brain targeting”, Curr Drug Deliv. 2(2) (2005), 165–175.
   PubMedGoogle Scholar
• Dhanda DS, Frey WH, Leopold Donald, and Kompella UB, “Approaches for drug deposition in the human olfactory epithelium”, Drug Del Technol. 5(4) (2005).
   Google Scholar
• Behl CR, Pimplaskar HK, Sileno AP, Meireles JDe, and VDRomeo, “Effects of physicochemical properties and other factors on systemic nasal delivery”, Adv Drug Del Rev. 29(1-2) (1998), 89–116.
   PubMed Web of Science ®Google Scholar
• Hu Z, Tawa R, Konishi T, Shibata N, and Takada K, “A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin”, Life Sci. 69(24) (2001), 2899–2910.
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Verbeke N, and Kinget R, “The biopharmaceutical aspects of nasal mucoadhesive drug delivery”, J. Pharm Pharmacol. 53(2001), 3–22(20).
   PubMedGoogle Scholar
• Alpar HO, Somavarapu S, Atuah KN, and Bramwell VW, “Bio- degradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery”, Adv Drug Del Rev. 57(3) (2005), 411–430.
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Sanna V, Cossu M, and Giunchedi P, “Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: In-vitro/ex-vivo studies”, J Pharm Pharmacol. 57(2005), 287–294.
   PubMed Web of Science ®Google Scholar
• Sakane T, Yamashita S, Yata N, and Sezaki H “Transnasal delivery of 5-fluorouracil to the brain in the rat”, J Drug target. 7(3) (1999), 233–240.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, and Rees GD, “Microemulsion based media as novel drug delivery systems”, Adv. Drug Deliv. Rev. 45(1)(2000), 89–121.
   PubMed Web of Science ®Google Scholar
• Sinswat P, and Tengamnuay P, “Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats; comparison with hydroxypropyl and dimethyl-beta-cyclodextrins”, Int. J. Pharm. 257 (2003), 15–22.
   PubMed Web of Science ®Google Scholar
• Florey Klaus, Analytical Profiles of Drug substances, Academic press, New York, Harcourt Brace Jonovich Publishers, 1(81) (1997).
   Google Scholar
• Florey Klaus, Analytical Profiles of Drug substances, Academic press, New York, Harcourt Brace Jonovich Publishers, 4(398) (1997a).
   Google Scholar
• Roland I, Piel G, Delattre L, and Evrard B. “Systemic characterization of oil-in-water emulsions for formulation design”, Int J Pharm. 263(1) (2003), 85–94.
   PubMedGoogle Scholar
• Bol CJ, Vogelaar JG, W JP, Tang JP, and Mandema JW, “Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat”, J. Pharmacol. Exp. Ther. 294(1) (2000), 347–355.
   PubMed Web of Science ®Google Scholar
• Zhang Qizhi, Jiang Xinguo, Xiang Wenming, Lu Wei, Su Lina, and Shi Zhenqui, “Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation of the targeting efficiency to brain”, Int J Pharm 275(1,2) (2004), 85–96.
   PubMedGoogle Scholar
• Lianli Li, Nandi I, and Kim KH, “Development of an ethyl laurate-based microemulsion for rapid-onset intranasal administration of diazepam”, Int J Pharm. 237(1, 2) (2002), 77–85.
   PubMedGoogle Scholar
• Vyas TK, Sharma RK, and Misra A, “Preliminary brain targeting studies of intranasal mucoadhesive microemulsions of sumatriptan”, AAPS Pharm Sci Tech. 7(1) (2006), Article 8.
   PubMed Web of Science ®Google Scholar
• Vyas TK, Sharma RK, and Misra A, “Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting”, J Pharm Sci. 95(3) (2006), 570–580.
   PubMed Web of Science ®Google Scholar
• Jogani ViralV, Shah PranavJ, Mishra Pushpa, Mishra AnilKumar, and Misra Ambikanandan, “Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting”, Alzheimer Dis Assoc Disord, (2007).
   Web of Science ®Google Scholar